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 2 
Abstract 28 
 29 
The Type VI secretion system (T6SS) is an injection apparatus that uses a spring-like 30 
mechanism for effector delivery. The contractile tail is composed of a needle tipped by a 31 
sharpened spike and wrapped by the sheath that polymerizes in an extended conformation on 32 
the assembly platform or baseplate. Contraction of the sheath propels the needle and effectors 33 
associated with it into target cells. The passage of the needle through the cell envelope of the 34 
attacker is assured by a dedicated trans-envelope channel complex. This membrane complex 35 
(MC) comprises the TssJ lipoprotein, and the TssL and TssM inner membrane proteins. MC 36 
assembly is a hierarchized mechanism in which the different subunits are recruited in a 37 
specific order: TssJ, TssM and then TssL. Once assembled, the MC serves as a docking 38 
station for the baseplate. In enteroaggregative Escherichia coli, the MC is accessorized by 39 
TagL, a peptidoglycan-binding (PGB) inner membrane-anchored protein. Here we show that 40 
the PGB domain is the only functional domain of TagL, and that the N-terminal 41 
transmembrane region mediates contact with the TssL transmembrane helix. Finally, we 42 
conduct fluorescence microscopy experiments to position TagL in the T6SS biogenesis 43 
pathway, demonstrating that TagL is recruited to the membrane complex downstream TssL 44 
and is not required for baseplate docking. 45 
 46 
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 Importance 50 
 51 
Bacteria use weapons to deliver effector into target cells. One of these weapons, called Type 52 
VI secretion system (T6SS), could be compared to a nano-speargun using a spring-like 53 
mechanism for effector injection. By targeting bacteria and eukaryotic cells, the T6SS 54 
reshapes bacterial communities and hijacks host cell defences. In enteroaggregative 55 
Escherichia coli, the T6SS is a multiprotein machine that comprises a cytoplasmic tail and a 56 
peptidoglycan-anchored trans-envelope channel. In this work, we show that TagL comprises a 57 
N-terminal domain that mediates contact with the channel, and a peptidoglycan-binding 58 
domain that binds the cell wall. We then determine at which stage of T6SS biogenesis TagL is 59 
recruited and how TagL absence impacts the assembly pathway.  60 
 4 
Introduction 61 
 62 
Bacteria have evolved sophisticated mechanisms to attack or defend against competitors that 63 
share the same environment, such as different bacterial species, amoeba, other unicellular 64 
microorganisms, or fungi (1,2). Among those, the Type VI secretion system (T6SS) is a 65 
multi-protein complex that is widespread in Gram-negative bacteria (3-9). The T6SS is 66 
capable of delivering effectors in bacteria and eukaryotic cells and is therefore an important 67 
player in inter-bacterial competition and pathogenesis (10-14). At the molecular level, the 68 
T6SS can be architecturally and mechanistically compared to a nano-crossbow or -speargun 69 
(6,15). It is related to a broad family of contractile injection systems (CIS) that include 70 
bacteriophages, R-pyocins and anti-feeding prophages (16-19). CIS comprise a spring-like 71 
structure, called the tail, composed of an inner tube terminated by a spike, wrapped by a 72 
contractile sheath and built on an assembly platform (18,19). Once in contact with the target 73 
cell, the sheath contracts and hence propels the inner tube/spike needle. The T6SS tail tube is 74 
made of Hcp hexamers stacked on each other and tipped by a trimer of the VgrG spike 75 
protein, which is further sharpened by the metal-bound PAAR protein (20-24). The 76 
contractile sheath that wraps the inner tube is composed of two proteins, TssB and TssC 77 
(15,25-28). The T6SS tail assembly platform or baseplate comprises the TssEFGK subunits 78 
that form a complex similar to bacteriophage baseplate wedges (29-32). Similarly to 79 
bacteriophages, six TssEFGK wedges polymerize around the VgrG spike to form the 80 
functional baseplate (31-32). Once the baseplate is assembled, the TssA protein will control 81 
the polymerization of the tube and of the sheath by adding tube and sheath building blocks 82 
from the distal end until it contacts the TagA stopper at the opposite membrane (33-37). In 83 
addition to the conserved CIS tail, T6SSs comprise an additional trans-envelope complex that 84 
anchors the tail to the cell envelope, positions the tail for firing toward the exterior, and serves 85 
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as a channel for the passage of the inner tube (38,39). The membrane complex (MC) is 86 
composed of three proteins: TssJ, TssL and TssM. TssJ is an outer membrane lipoprotein 87 
whereas TssL and TssM are two inner membrane proteins, inserted by one and three 88 
transmembrane helices (TMHs) respectively (40-43). TssL dimerizes and interacts with TssM 89 
by its single TMH (42,44,45), whereas the C-terminal region of the TssM periplasmic domain 90 
binds to TssJ (39,46). The negative-stain and cryo-electron microscopy, and cryo-electron 91 
tomography structures of the 1.7-MDa T6SS MC from enteroaggregative Escherichia coli 92 
(EAEC) have been reported, defining a rocket-like shape, with a large cytoplasmic base 93 
followed by arches likely corresponding to the TssL and TssM TMHs, and by pillars crossing 94 
the periplasm and corresponding to the TssM periplasmic domain and TssJ lipoprotein 95 
(39,47,48). The central portion of the MC defines a channel that is narrowed at the 96 
periplasmic entrance and closed at its outer membrane extremity, suggesting that the MC 97 
undergoes significant conformational changes during firing to allow the passage of the needle 98 
(39,47). The cytoplasmic base of the membrane complex represents the docking station for 99 
the assembled baseplate, mainly by contacts between the C-terminal domain of the baseplate 100 
TssK subunit with the cytoplasmic domains of TssL and TssM (30,32,43,49-52). The 101 
assembly of the membrane complex starts with the positioning of the TssJ lipoprotein and the 102 
ordered recruitment of TssM and TssL (39). Polymerization of the TssJLM complex to 103 
assemble the MC requires local remodeling of the peptidoglycan, which is assured by a 104 
dedicated or housekeeping transglycosylase (53,54). In most T6SS, the MC is stably anchored 105 
to the cell wall by a peptidoglycan-binding (PGB) domain (38,55). In most cases, the PGB 106 
domain is fused to the C-terminus of the TssL TMH (Fig. 1). However, other T6SS have 107 
evolved different strategies to be anchored to the peptidoglycan layer, such as accessory inner 108 
membrane or periplasmic proteins bearing a PGB domain (55). In EAEC, the PGB domain is 109 
carried by the accessory protein TagL that associates with the membrane complex by directly 110 
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interacting with TssL (38). TagL is constituted of three TMHs and the periplasmic PGB 111 
domain (Fig. 1)(38). Mutations within the PGB that prevent peptidoglycan binding in vivo 112 
and in vitro abolish T6SS activity, demonstrating that TagL-mediated anchoring to the cell 113 
wall is necessary for T6SS function (38). Here we show that fusing the TagL PGB to the C-114 
terminus of TssL is sufficient to compensate for the absence of tagL, demonstrating that the 115 
PGB domain is the only functional domain of TagL. We further demonstrate that TagL-TssL 116 
complex formation is mediated by interactions between their TMHs. We then generated a 117 
functional sfGFP-TagL protein and showed by fluorescence microscopy that it co-localizes 118 
with TssL at the base of the sheath, and is recruited downstream TssL but upstream baseplate 119 
docking. Finally, microscopy recordings of functional GFP fusions to T6SS subunits in 120 
absence of tagL demonstrate that TagL is not necessary for recruitment of TssA and of the 121 
baseplate, but required for sheath polymerization.  122 
 123 
Results 124 
TagL PGB fusion to TssL bypasses the requirements for full-length TagL. 125 
The EAEC T6SS sci1 gene cluster encodes TagL, a three-TMH inner membrane 126 
protein that bears a periplasmic peptidoglycan-binding (PGB) domain (38) (Fig. 1). Binding 127 
to the cell wall is required for T6SS function as TagL PGB amino-acid substitutions that 128 
prevent in vitro and in vivo interaction with the peptidoglycan abolish T6SS activity (38). 129 
However, although TagL is not broadly conserved in T6SSs, T6SS gene clusters usually 130 
encode a PGB domain that can be either carried by an accessory protein or fused to the TssL 131 
core component (55) (Fig. 1). We therefore asked whether the N-terminal transmembrane 132 
portion of TagL is necessary for T6SS function. For this, we engineered a strain deleted of 133 
both tssL and tagL. ∆tssL-tagL cells, as well as ∆tssL-tagL cells expressing tssL or tagL only, 134 
were unable to release Hcp in the culture supernatant, and to outcompete E. coli K-12 cells in 135 
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antibacterial assays (Fig. 2A and Fig. 2B), in agreement with the essential roles of TssL and 136 
TagL in EAEC T6SS (38,42). However, a plasmid-borne fragment encoding both TssL and 137 
TagL complemented the phenotypes associated with the ∆tssL-tagL deletion to wild-type 138 
levels (Fig. 2A and Fig. 2B). Interestingly, fusion of the TagL periplasmic PGB domain at the 139 
C-terminus of TssL to yield the TssL-PGB chimera protein was sufficient to promote T6SS 140 
activity in ∆tssL-tagL cells (Fig. 2A and Fig. 2B). This result demonstrates that the C-terminal 141 
PGB domain is the only functional domain of TagL. In agreement with this observation, 142 
production of the TssL-PGB chimera protein bearing substitutions that prevent anchorage of 143 
the PGB domain to the cell wall (TssL-PGB*, N494L/L497N/S498A/R501Q/A502D 144 
substitutions; 38) was unable to restore T6SS activity in ∆tssL-tagL cells (Fig. 2A and Fig. 2B). 145 
 146 
The TagL N-terminal region mediates interaction with the TssL TMH. 147 
 The observation that the PGB domain of TagL (orange in Fig. 3A and 3B) is necessary 148 
and sufficient for T6SS raised the question of the role of its N-terminal region, that comprises 149 
three TMHs, a short periplasmic linker connecting TMH1 and TMH2, and a cytoplasmic 150 
domain located between TMH2 and TMH3 (blue in Fig. 3A and 3B). We hypothesized that 151 
this region might engage in the interaction with TssL. To test whether the TagL N-terminal 152 
region is important for TagL-TssL complex formation, we performed co-precipitation 153 
analyses. As previously shown (38), precipitation of 6×His-tagged TagL on nickel magnetic 154 
beads co-precipitated TssL (Fig. 3C, lanes 3 and 4). However, TagL did not co-precipitate 155 
TssLC, a TssL variant deleted of its C-terminal TMH (red in Fig. 3A and 3B)(Fig. 3C, lanes 5 156 
and 6), suggesting that TagL-TssL complex formation does not require interactions between 157 
their cytoplasmic domain, and thus that it likely involves their TMHs. In agreement with this 158 
hypothesis, a TagL variant deleted of its periplasmic domain but retaining its three TMHs 159 
(TagL∆P, blue in Fig. 3A and 3B) co-precipitated TssL at comparable levels to full-length 160 
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TagL (Fig. 3C, lanes 7 and 8). From these results, we conclude that the TagL periplasmic 161 
region, that includes the PGB domain, and the TssL cytoplasmic domain, do not contribute to 162 
TagL-TssL complex formation and hence that the interaction between the two partners is 163 
likely mediated by their TMHs. Taken together, the results of Figures 2 and 3 suggest that the 164 
TagL PGB domain is a functional module for T6SS activity whereas its TMHs are required 165 
for recruitment to the T6SS MC via direct interactions with the TssL TMH. 166 
 167 
TagL colocalizes with the membrane complex at the base of the tail. 168 
To define the localization and dynamics of TagL in wild-type EAEC cells, we 169 
engineered a chromosomally-encoded superfolder Green Fluorescent Protein (sfGFP) fusion 170 
to TagL, by inserting the sfGFP-encoding fragment in frame, downstream the tagL ATG start 171 
codon. Hence, sfGFP-TagL is produced from the native locus, under the expression signals of 172 
tagL. Antibacterial assays demonstrated that this sfGFP-TagL fusion is functional as sfGFP-173 
TagL-producing cells outcompete E. coli K-12 competitor cells (Fig. S1). Fluorescence 174 
microscopy analyses showed that sfGFP-TagL clusters in foci in EAEC cells (Fig. 4A). Time-175 
lapse recordings further showed that these foci remain static (Fig. 4A). Quantitative and 176 
distribution analyses demonstrated that most cells contain less than 2 foci per cell (Fig. 4B), 177 
and that sfGFP-TagL foci localize in all the cell body with an underrepresentation at the cell 178 
poles (Fig. 4C). The number of foci per cell and their spatial distribution is comparable to 179 
what has been previously reported for sfGFP-TssL and sfGFP-TssM in EAEC (39). In 180 
agreement with this observation, and with previous protein-protein interaction data showing 181 
that TagL interacts with TssL (38; Fig. 3C), fluorescence microscopy analyses of EAEC cells 182 
producing both sfGFP-TagL and TssL fused to mCherry (mCh-TssL) demonstrated that in 183 
most cases TagL and TssL co-localize (Fig. 4D). In some cases, only a mCh-TssL focus was 184 
visible without evidence for the presence of sfGFP-TagL (see white arrow in Fig. 4D). While 185 
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we cannot rule out that some MC may assemble without TagL, we hypothesize that these 186 
cases represent assembly intermediates, in which TagL has not been recruited yet to the MC. 187 
Nevertheless, these results suggest that TagL co-localizes with the MC, and hence should be 188 
located at the base of the extended sheath. Indeed, sfGFP-TagL foci localize at one extremity 189 
of the T6SS sheath (Fig. 4E). Time-lapse recordings further showed that the sheaths contract 190 
on sfGFP-TagL foci (Fig. 4F) demonstrating that TagL localizes at the base of the sheath. 191 
 192 
Recruitment and role of TagL during T6SS biogenesis in EAEC 193 
T6SS biogenesis is a hierarchized pathway, in which subunits or complexes are 194 
recruited in a strict order. T6SS biogenesis is initiated by the assembly of the MC (39) and 195 
pursued by the docking of the BP (30,32) and the extension of the tail tube/sheath structure 196 
(30,39). TssA is recruited to the TssJM complex and helps the recruitment of the BP complex 197 
prior to tail tube/sheath polymerization (33). Finally, TagA stops tail tube/sheath 198 
polymerization, and maintains the sheath under the extended conformation (37). We therefore 199 
wished to determine at which step TagL is recruited and how TagL absence impacts the T6SS 200 
biogenesis pathway.  201 
To define the requirements for TagL recruitment at the T6SS, we fused sfGFP to TagL 202 
in various mutant backgrounds deleted of T6SS genes. Fig. 5A shows that sfGFP-TagL 203 
localizes in foci in absence of TssK, TssA or of the TssBC sheath subunits. In addition, 204 
statistical analyses showed that the absence of these T6SS subunits does not significantly 205 
impact the localization and distribution of sfGFP-TagL foci (Fig. S2). These results suggest 206 
that TagL is recruited to the apparatus prior to BP assembly and docking to the MC.  207 
Biogenesis of the MC starts with the positioning of TssJ and the subsequent recruitment of 208 
TssM and TssL (39). Then, TssJLM complexes polymerize to assemble the MC once the cell 209 
wall has been locally degraded by MltE (54). Fluorescence microscopy experiments showed 210 
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that TssJ, TssM, TssL and MltE are necessary for sfGFP-TagL recruitment (Fig. 5A), 211 
suggesting that TagL binds to the MC once this complex has been fully assembled.  212 
Based on these results, we hypothesized that TagL should not be required for MC 213 
assembly, but will be necessary for BP docking. To verify this hypothesis, we deleted the 214 
tagL gene in EAEC cells producing sfGFP-TssM, -TssL, -TssA, TssK-sfGFP or TssB-mCh 215 
from their native loci. As expected, the absence of TagL does not impact the recruitment of 216 
TssM nor TssL (Fig. 5B). However, by contrast to our initial hypothesis, TssA and TssK 217 
formed foci in absence of TagL (Fig. 5B). Statistical analyses showed that the number of 218 
sfGFP-TssM, -TssL, -TssA, and TssK-sfGFP foci per cell is not impacted by the absence of 219 
TagL (Fig. S3), suggesting that TagL does not participate to the stability of the T6SS MC and 220 
BP complexes. Taken together, these results demonstrate that TagL binding to the MC is not a 221 
prerequisite for BP docking. Interestingly, although the absence of TagL does not prevent 222 
TssA recruitment to the MC, TssA forms static foci which do not move to the opposite 223 
membrane in ∆tagL cells (Fig. S4A) suggesting that TagL is necessary for sheath extension. 224 
Indeed, no sheath structure was observable in absence of TagL (Fig. 5B). Finally, because 225 
previous data have shown that the MC is static over time (39), we asked whether TagL-226 
mediated interaction with the cell wall stabilizes the MC and prevents its diffusion in the cell 227 
envelope. This hypothesis is however unlikely as time-lapse recordings showed that sfGFP-228 
TssM foci remain static in absence of TagL (Fig. S4B). 229 
Taken together our fluorescence microscopy observations demonstrate that TagL is 230 
recruited once the MC is fully assembled, is dispensable for the assembly of the MC and for 231 
the docking of the BP, but is necessary for tail sheath extension (Fig. 5C).  232 
 233 
Discussion 234 
 235 
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In this work, we provide details on the role of the TagL peptidoglycan-binding protein 236 
for T6SS function, and during T6SS biogenesis in EAEC.  237 
TagL comprises two domains: a N-terminal domain constituted of three TMHs that 238 
mediate interaction with the TssL TMH, and a C-terminal domain that binds the cell wall. Our 239 
results show that the PGB domain is the only functional domain of TagL, as a fusion protein 240 
between TssL and the TagL PGB domain is sufficient to support T6SS activity. Based on this 241 
observation, we hypothesize that the TagL N-terminal transmembrane domain is only 242 
necessary to bind TssL and hence to accessorize the T6SS with the PGB domain. 243 
Interestingly, previous analyses have shown that most T6SS gene clusters encode for proteins 244 
with peptidoglycan-binding motifs. However, these proteins come in many flavors: inner 245 
membrane-anchored accessory proteins such as TagL or TagP, predicted periplasmic proteins 246 
such as TagN or TagW, or PGB domain fused to the TssL core-component ("specialized" 247 
TssL) (55). A detailed phylogenetic study of these proteins would be required to understand 248 
how these genes have been acquired, how they have evolved to accessorize the T6SS. One 249 
interesting question is whether specialized TssL arose from a reduction of the gene cluster by 250 
fusing the PGB domain of TagL/TagN/TagP/TagW to TssL, or whether 251 
TagL/TagN/TagP/TagW evolved from the partition of the TssL core and PGB domains. Our 252 
observations that TagL PGB domain fusion to TssL bypasses the requirement for full-length 253 
TagL and that its TMHs are only necessary to mediate contact with TssL tend to support the 254 
reduction hypothesis.  255 
By using deletion variants, we have shown that TssL-TagL complex formation is 256 
mediated by their TMHs. While we have not defined which of the three TagL TMHs is 257 
implicated in the interaction with the TssL C-terminal TMH, previous studies have reported 258 
that the TssL TMH is engaged in interaction with itself and with the TssM TMHs (39,43,45). 259 
Because there is no conserved sequence homology or helical motifs between the TagL and 260 
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TssM TMHs, we suggest that TagL and TssM do not share the same face of interaction on the 261 
TssL TMHs, and hence that TssL-TagL and TssL-TssM interactions are not exclusive. This 262 
hypothesis is in agreement with previous data reporting the co-precipitation of a ternary 263 
TssM-TssL-TagL complex (38). These observations suggest that in addition to the tryptophan 264 
residues engaged in π-π interactions in the TssL TMH dimer (45), two additional faces of the 265 
TssL TMH are involved in TssM and TagL interactions. Further studies need to be performed 266 
to better understand the organization of the TMHs of the TssM-TssL-TagL complex in the 267 
inner membrane.  268 
In this work, we performed a comprehensive fluorescence microscopy analysis to 269 
position TagL in the T6SS biogenesis pathway. By using a functional sfGFP-TagL fusion, we 270 
showed that TagL co-localizes with TssL at the base of the extended sheath, in agreement 271 
with TagL association with the MC. From our time-lapse fluorescence recordings of cells 272 
producing both sfGFP-TagL and TssB-mCherry, one can notice that TagL remains at the MC 273 
during sheath contraction, suggesting that TagL is associated with TssL during all the T6SS 274 
mechanism of action. We can hypothesize that TagL-mediated PG-anchoring is important to 275 
stabilize the MC and to prevent its dissociation by the mechanical strength generated by 276 
sheath contraction (15). Our analyses of sfGFP-TagL foci formation in various T6SS mutant 277 
backgrounds revealed that positioning TagL at the site of T6SS assembly requires TssJ, 278 
TssM, TssL and MltE, but does not require TssK, TssA or TssBC. Therefore TagL is 279 
recruited to the MC prior to BP docking. Because the MltE lytic transglycosylase enables full 280 
assembly of the MC by locally remodeling the cell wall (54), these results suggest that TagL 281 
is recruited to the MC when its assembly is completed (Fig. 5C). Indeed, TagL, and TagL-282 
mediated PG-anchoring, is not required for MC assembly, in agreement with the facts that 283 
TagL is an accessory protein that is not conserved in all T6SS (38,55) and that the MC can be 284 
purified from E. coli K-12 cells lacking TagL (39). However, although TagL is recruited 285 
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upstream the BP, it is not necessary for BP docking to the MC (Fig. 5C). This result clearly 286 
shows that the T6SS biogenesis pathway is not a strict linear pathway, with the ordered 287 
recruitment of one subunit after the other, but rather that independent branches exist. 288 
However, while the BP docks to the MC in ∆tagL cells, extension of the tail/tube cannot 289 
proceed in absence of TagL. This observation hence suggests that once the BP docks to the 290 
MC, TagL mediates a structural modification of the MC or BP that is required to initiate 291 
sheath extension. Electron microscopy models of the MC bound to TagL or of the MC-BP 292 
complex would likely provide further information on the impact of TagL on the 293 
conformations of the MC or BP. 294 
 295 
Material and Methods 296 
 297 
Bacterial strains, media, growth conditions, and chemicals.  298 
Bacteria strains are listed in Supplemental Table S1. Escherichia coli K-12 DH5α and W3110 strains 299 
were used for cloning procedures, and co-immunoprecipitations, respectively. Escherichia coli K-12 300 
W3110 cells carrying the pFPV-mCherry plasmid (mCherry under the constitutive and strong 301 
ribosomal rpsM promoter, AmpR; 56) were used as recipients for the antibacterial competition assays. 302 
The enteroaggregative E. coli (EAEC) wild-type strain 17-2, its ∆tagL, ∆tssM, ∆tssL, ∆tssJ, ∆tssA, and 303 
∆tssK derivatives and 17-2 strains producing the TssB-mCh, TssB-sfGFP, sfGFP-TssA, sfGFP-TssM, 304 
sfGFP-TssL, mCh-TssL, and TssK-sfGFP fusion from their native chromosomal loci have been 305 
previously described (30,33,38-40,49). Strains were routinely grown in LB broth at 37°C with 306 
aeration. For induction of the T6SS sci1 genes, strains were grown in Sci1 inducing medium (SIM; 307 
M9 minimal medium supplemented with glycerol 0.25%, vitamin B1 1 μg.mL−1, casaminoacids 40 308 
μg.mL−1, and 10% v/v of LB; 57). Plasmids and mutations were maintained by the addition of 309 
ampicillin (100 µg.mL-1 for K-12, 200 µg.mL-1 for EAEC), kanamycin (50 µg.mL-1 for K-12, 50 310 
µg.mL-1 for chromosomal insertion on EAEC, 100 µg.mL-1 for plasmid-bearing EAEC). Gene 311 
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expression from pASK-IBA vectors was induced for 30 min with 0.05 µg.mL-1 of anhydrotetracyclin 312 
(AHT, IBA Technologies).  313 
 314 
Strain construction. 315 
The 17-2 derivative strains were engineered by O-red recombination (58) using plasmid pKOBEG 316 
(59). For construction of the 17-2 strain deleted of tagL or of both tssL and tagL (∆tssL-tagL), a 317 
kanamycin cassette was amplified from plasmid pKD4 (58) with primers carrying 50-bp extensions 318 
corresponding to the 5' and 3' sequences of the region to be deleted. For construction of 17-2 strain 319 
derivatives producing sfGFP-TagL, a kanamycine-sfGFP cassette was amplified from the pKD4-Nter-320 
sfGFP vector (39) with primers carrying 50-bp extensions corresponding to the upstream and 321 
downstream regions of the tagL initiation codon. PCR products were electroporated into target cells, 322 
and O-red-mediated recombination at the proper locus was verified by PCR. The excision of the 323 
kanamycin cassette, when possible, was then obtained by production of the Flp recombinase using 324 
pCP20 (58). The final strains were verified by PCR. 325 
 326 
Plasmid construction. 327 
Plasmids used in this study are listed in Supplemental Table S1. Polymerase Chain Reactions (PCR) 328 
were performed with a Biometra thermocycler, using the Pfu Turbo DNA polymerase (Stratagene). 329 
Custom oligonucleotides were synthesized by Sigma-Aldrich and are listed in Supplemental Table S1. 330 
The pASK-IBA37(+) vector producing N-terminally 6×His-tagged TagL (initially called pIBA-28; 331 
38), the FLAG-tagged TssL or TssL fused to the periplasmic domain (amino-acids 360-576) of TagL 332 
(TssL-PGB, initially named pIBA-SciP and pIBA-SciP-PG; 42), and the pOK12 derivatives producing 333 
N-terminally HA-tagged Hcp (38) or TssL (initially named pOK-SciP-HA; 38) have been previously 334 
described. The pOK12 plasmid producing the TssL cytoplasmic domain (amino-acids 1-186, TssLC) 335 
was constructed by standard restriction/ligation cloning by inserting a EcoRI-tssLC-XhoI fragment into 336 
EcoRI-XhoI-digested pOK12 derivative plasmid pMS600 (40). Plasmid producing TagL deleted of 337 
the periplasmic region (TagL∆P) has been constructed by replacing tagL codon 366 by a TAA stop 338 
codon on pIBA-TagL, using site-directed mutagenesis and primers carrying the desired substitutions. 339 
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The pIBA-TssL-TagL plasmid, producing both TssL and TagL, and pIBA-TssL-PGB*, producing 340 
TssL fused to the TagL mutated PGB domain (PGB*, Asn494Leu-Leu497Asn-Ser498Ala-341 
Arg501Gln-Ala502Asp substitutions; 38), have been constructed by restriction-free cloning (38,60). 342 
Briefly, the sequences encoding the TssL protein, or the mutated PGB domain of TagL were amplified 343 
from 17-2 DNA and plasmid pIBA-TagL-PG* (38) respectively, with oligonucleotides carrying 5' 344 
extensions annealing upstream and downstream the site of insertion on the target plasmid. The 345 
products of the first PCR were then used as oligonucleotides for a second PCR using the target vector 346 
as template. The tssL fragment was inserted into plasmid pIBA-TagL, whereas the PGB*-encoding 347 
fragment was inserted into plasmid pIBA-TssL. All constructs have been verified by restriction 348 
analyses and DNA sequencing (Eurofins genomics). 349 
 350 
T6SS function reporter assays. 351 
The Hcp release assay was performed as described (40), using plasmid pOK-HcpHA, except that cells 352 
were grown in SIM to an absorbance at λ = 600 nm (A600) of 0.6. The periplasmic TolB protein was 353 
used as control for cell integrity. The interbacterial competition assay has been performed as described 354 
(61) with modifications as follows: (i) E. coli W3110 cells constitutively expressing the mCherry from 355 
plasmid pFPV-mCherry (AmpR; 56) has been used as recipients, (ii) fluorescence measurements with 356 
the TECAN microplate reader were performed by exciting the mCherry at λ = 575 nm, and recording 357 
its emission at λ = 610 nm, and (iii) survival of recipient cells was calculated by counting colony 358 
forming units (cfu) on recipient-selective LB plates supplemented with ampicillin.  359 
 360 
Co-precipitation on nickel magnetic beads. 361 
5×109 E. coli W3110 cells producing the proteins of interest were harvested, and resuspended in 362 
CelLytic B lysis reagent (Sigma-Aldrich) supplemented with 100 μg.mL-1 lysozyme, 100 μg.mL-1 363 
DNase, protease inhibitors (Complete, Roche), and 1.65 mM octylphenoxy poly(ethyleneoxy)ethanol 364 
(Igepal® CA-630, Sigma-Aldrich). After 30-min incubation at 25°C with strong agitation, 365 
unsolubilized material was discarded by centrifugation for 20 min at 20,000×g. The cleared lysates 366 
were supplemented with imidazole 10 mM and incubated with Nickel magnetic beads 367 
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(PureProteomeTM, Millipore) for 2 hours at room temperature on a wheel. Magnetic beads were then 368 
washed three times with CelLytic B lysis reagent supplemented with Igepal CA-630 and imidazole 20 369 
mM, resuspended in non-reducing Laemmli loading dye, and subjected to sodium-dodecylsulphate 370 
poly-acrylamide gel electrophoresis (SDS-PAGE) and immuno-blot analyses using monoclonal anti-371 
His and anti-HA antibodies.  372 
 373 
Fluorescence microscopy and data analysis.  374 
Cells producing the chromosomal sfGFP or mCherry fusion proteins were grown in SIM to a A600 of 375 
0.6–0.8, harvested and resuspended in SIM to a A600 of 8. Cells were then spotted on a thin pad of SIM 376 
supplemented with 2% agarose, covered with a cover slip and incubated for 20-30 min at room 377 
temperature before microscopy acquisition. Fluorescence microscopy recordings were performed with 378 
a Nikon Eclipse Ti microscope equipped with an Orcaflash 4.0 LT digital camera (Hamamatsu) and a 379 
perfect focus system (PFS) to automatically maintain focus so that the point of interest within a 380 
specimen is always kept in sharp focus at all times despite mechanical or thermal perturbations. All 381 
fluorescence images were acquired with a minimal exposure time to minimize bleaching and 382 
phototoxicity effects. Exposure times were typically 30 ms for phase contrast, 250 ms for sfGFP 383 
fusion proteins, and 200 ms for TssB-mCh and TssL-mCh. The images shown in the figures are 384 
representative regions cropped from large fields, from at least triplicate experiments. Images were 385 
analyzed using ImageJ (62) and the MicrobeJ plugin (63). Statistical dataset analysis was performed 386 
using the R software environment (https://www.r-project.org/).  387 
 388 
Miscellaneous. 389 
SDS-PAGE and transfer onto nitrocellulose membranes (Amersham Protran 0.2 µm, GE Healthcare) 390 
have been performed with standard procedures using Mini-Protean II systems (Biorad). After protein 391 
transfer, membranes were probed with primary antibodies and goat secondary antibodies coupled to 392 
alkaline phosphatase. Immunodetections were performed in alkaline buffer in presence of 5-bromo-4-393 
chloro-3-indolylphosphate and nitroblue tetrazolium. The anti-FLAG (clone M2, Sigma-Aldrich), 394 
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anti-HA (clone HA-7, Sigma-Aldrich) anti-Histidine tag (clone AD1.1.10, Biorad) monoclonal 395 
antibodies, and alkaline phosphatase-conjugated goat anti-mouse and anti-rabbit secondary antibodies 396 
(Beckman Coulter) are commercially available. The anti-TolB polyclonal antibodies are from the 397 
laboratory collection. 398 
 399 
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Legend to Figures 582 
 583 
Figure 1. Schematic representations of selected T6SS subunits that bind the cell wall. In 584 
EAEC and other species, T6SS gene clusters encode TssL and TagL, a three-TMH protein 585 
with a periplasmic peptidoglycan-binding (PGB) domain (shown in orange). In the vast 586 
majority of cases, the PGB domain is fused to TssL to yield the TssL-PGB specialized TssL 587 
protein. Additional cases have been described by (55). IM, inner membrane; PG, 588 
peptidoglycan; OM, outer membrane. 589 
 590 
Figure 2. The PGB domain is the only functional domain of TagL. T6SS functional assays 591 
of wild-type (WT) cells, and ∆tssL-tagL cells bearing the pASK-IBA37(+) empty vector (-) or 592 
the pASK-IBA37(+) vector encoding TssL, TagL, both TssL and TagL, the TagL PGB fused 593 
to TssL (TssL-PGB) or the mutated TagL PGB fused to TssL (TssL-PGB*). (A) Hcp release 594 
was assessed by separating whole cells (C) and supernatant (Sn) fractions from the indicated 595 
strains producing HA-tagged Hcp from the pOK-HcpHA vector. 2×108 cells and the TCA-596 
precipitated material of the supernatant from 5×108 cells were subjected to 12.5%-acrylamide 597 
SDS-PAGE and immunodetected using the anti-HA monoclonal antibody (lower panel) and 598 
the anti-TolB polyclonal antibodies (lysis control; upper panel). The positions of HcpHA and 599 
TolB are indicated on the right. Molecular weight markers (in kDa) are indicated on the left. 600 
(B) E. coli K-12 recipient cells (W3110 mCherry, AmpR) were mixed with the indicated 601 
attacker cells, spotted onto SIM agar plates and incubated for 4 h at 37 °C. The image of a 602 
representative bacterial spot is shown below the graph reporting the fluorescence level of the 603 
spots (in arbitrary units). The average fluorescence and standard deviation are indicated, as 604 
well as the values from nine independent measurements (grey dots). The lower graph reports 605 
the number of surviving E. coli recipient cells [counted on selective ampicillin medium; in 606 
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log10 of colony-forming units (cfu)]. The grey dots correspond to the nine values from three 607 
independent biological replicates. The average is indicated by the horizontal bar.  608 
 609 
Figure 3. TssL and TagL interact via their TMHs. (A) Schematic representation of the 610 
EAEC T6SS. The membrane complex comprises TssJ (dark grey), TssM (light grey), TssL 611 
(red, N-terminal cytoplasmic domain [TssLC]; green, C-terminal TMH) and TagL (blue, N-612 
terminal membrane domain [TagL∆P]; orange, C-terminal peptidoglycan-binding domain). 613 
The baseplate is shown in green. The contractile tail in shown in blue. The TssA protein, 614 
located at the distal end of the tail is shown in red. IM, inner membrane; PG, peptidoglycan; 615 
OM, outer membrane. (B) Schematic representation of EAEC TssL and TagL highlighting 616 
their topologies (38,42) and different domains (same colours as Fig. 3A). The three TagL 617 
TMHs are numbered (1 to 3 from the N-terminus). (C) Co-precipitation assay. Igepal® CA-618 
630-solubilized extracts of E. coli cells producing the indicated proteins or protein variants 619 
were mixed with Nickel magnetic beads to precipitate 6×His-tagged TagL and interacting 620 
partners. The total lysates (T) and eluted (E) material were subjected to 12.5%-acrylamide 621 
SDS-PAGE and immunodetected with anti-His (TagL, upper panel) and anti-HA (TssL, lower 622 
panel) monoclonal antibodies. The positions of TssL, TagL and their variants are indicated on 623 
the right. Molecular weight markers (in kDa) are indicated on the left.  624 
 625 
Figure 4. Localization, dynamics, and distribution of TagL. (A) Representative 626 
fluorescence microscopy time-lapse recording of wild-type EAEC cells producing sfGFP-627 
TagL. Individual images were taken every 30 s. The white arrowhead highlights the position 628 
of one sfGFP-TagL focus showing that it is static over time. Scale bar, 2 μm. (B) Percentage 629 
of cells with 0, 1, 2 or >2 sfGFP-TagL foci (n = 1110 cells from four biological replicates). 630 
The mean number of foci per cell is 0.67 ± 0.86. (C) Spatial distribution of sfGFP-TagL foci. 631 
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Shown is a projection of the foci from n = 743 cells on a single cell (from blue to yellow, see 632 
heatmap color chart on left). (D) and (E) Representative cells producing sfGFP-TagL and 633 
mCherry-TssL (D) or TssB-mCherry (E). From left to right are shown the phase (Phase), 634 
sfGFP, and mCherry channels, an overlay of the sfGFP and mCherry channels (merge) and a 635 
schematic representation. White and blue arrowheads in panel (D) indicate isolated TssL foci 636 
and TssL/TagL foci, respectively. Scale bar, 1 μm. (F) Representative fluorescence 637 
microscopy time-lapse recording of a wild-type EAEC cell producing sfGFP-TagL and TssB-638 
mCherry. Individual images were taken every 30 s. A schematic representation is shown 639 
below. Scale bar, 1 μm. 640 
 641 
Figure 5. Localization and distribution of TagL. (A) Representative fluorescence 642 
microscopy fields of WT, ΔtssJ, ΔtssM, ΔtssL, ΔmltE, ΔtssK, ΔtssA and ΔtssBC cells 643 
producing sfGFP-TagL. Statistical analyses are shown in Fig. S2. Scale bar, 2 μm. (B) 644 
Representative fluorescence microscopy fields of wild-type (WT, upper panels) or ΔtagL 645 
(lower panels) cells producing sfGFP-TssM, sfGFP-TssL, sfGFP-TssA, TssK-sfGFP or TssB-646 
mCh. Statistical analyses are shown in Fig. S3. Scale bar, 1 μm. (C) Schematic representation 647 
of the EAEC T6SS biogenesis pathway based on previous studies (30,32,33,39,54) 648 
highlighting the position of TagL (shown in green). TagL is recruited after completion of the 649 
MC and prior to BP docking (plain green line). TssA recruitment, baseplate positioning 650 
(represented by TssK subunit in this study), and tail tube/sheath polymerization (represented 651 
by TssBC in this study) are not required for TagL localization, but TagL is necessary for tail 652 
tube/sheath polymerization (dotted green line). 653 
654 
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Legend to Supplemental Figures 655 
 656 
Figure S1. sfGFP-TagL is functional. E. coli K-12 recipient cells (W3110 mCherry, AmpR) 657 
were mixed with the indicated attacker cells, spotted onto SIM agar plates and incubated for 4 658 
h at 37 °C. The image of a representative bacterial spot is shown below the graph reporting 659 
the fluorescence level of the spots (in arbitrary units). The average fluorescence and standard 660 
deviation are indicated, as well as the values from nine independent measurements (grey 661 
dots). The lower graph reports the number of surviving E. coli recipient cells [counted on 662 
selective ampicillin medium; in log10 of colony-forming units (cfu)]. The grey dots 663 
correspond to the nine values from three independent biological replicates. The average is 664 
indicated by the horizontal bar. 665 
 666 
Figure S2. Impact of T6SS subunits on TagL localization. Number of sfGFP-TagL foci per 667 
cell in ∆tssJ (A), ∆tssM (B), ∆tssL (C), ∆mltE (D), ∆tssK (E), ∆tssA (F), and ∆tssBC (G) cells. 668 
The number of analyzed cells (n) from representative fields of three biological replicates is 669 
indicated on top of each graph. 670 
 671 
Figure S3. Impact of TagL on T6SS subunits localization.  Number of sfGFP-TssM (A), 672 
sfGFP-TssL (B), TssK-sfGFP (C), and sfGFP-TssA (D) foci per cell in wild-type (upper 673 
graphs) and ∆tagL (lower graphs) cells. The number of analyzed cells (n) from representative 674 
fields of three biological replicates is indicated on top of each graph. 675 
 676 
Figure S4. Impact of TagL on TssA and TssM recruitment and dynamics.  677 
Representative fluorescence microscopy time-lapse recordings of wild-type (WT, upper 678 
panels) or ΔtagL (lower panels) cells producing sfGFP-TssA (A) or sfGFP-TssM (B). 679 
 26 
Individual images were taken every 30 s. White arrowheads indicate the localization and 680 
dynamics of a TssA focus. Scale bar is 1 μm. 681 
 682 





